Institute Of Hematology And Blood Transfusion, Czech Republic

This early-phase study is testing the safety of a new personalized cell therapy called CART123 for adults with advanced blood cancers that have returned or not responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to target cancer,…